US$ 27.09
obesity drug news today glp-1 october 27 2025 McKee's proposed FY2027 budget drops drugs for weight loss from Medicaid • Rhode Island Current Novo, Lilly poised to overcome
Description
(), , trend or significant reduction in this parameter (weak, intermediate, or strong effect)

Dual Pancreatic Action: High GLP-1 levels tell the beta cells to release insulin and the alpha cells to stop releasing glucagon

For patients with known diabetic retinopathy who are candidates for GLP-1 therapy, additional precautions are warranted

Smriti Choudhary, M.D

doi: 10.1161/CIRCRESAHA.111.255505 15 HardieDG
